<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00159380</url>
  </required_header>
  <id_info>
    <org_study_id>2002AT033B</org_study_id>
    <nct_id>NCT00159380</nct_id>
  </id_info>
  <brief_title>Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects</brief_title>
  <official_title>A Double Blind, Crossover Placebo-controlled Study to Evaluate the Effect of L-arginine and Aminoguanidine on Bronchial, Alveolar and Nasal NO and NO Metabolites in Exhaled Air, Breath Condensate, Saliva, Nasal Lavage Fluid and Induced Sputum in 10 Normal and 15 Asthmatic Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <brief_summary>
    <textblock>
      The primary aim of this study is to investigate the effects of oral and inhaled
      administration of L-arginine and of inhaled aminoguanidine on bronchial and alveolar exhaled
      NO and NO metabolites in exhaled breath condensate, saliva and nasal lavage fluid in normal
      and asthmatic subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">March 2005</completion_date>
  <primary_completion_date type="Actual">March 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exhaled nitric oxide, exhaled breath condensate, nasal lavage, saliva, spirometry</measure>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Asthma</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Inhalation of aminoguanidine and oral intake and inhalation of L-arginine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Exhaled Breath Condensate</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nasal Lavage</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saliva</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spirometry</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Healthy non-smokers (n=10):

          -  Nonatopic subjects (exhaled NO greater than or equal to 10 ppb; flow 50 ml/s)

          -  Normal spirometry

          -  Able to comprehend and grant a written informed consent

        Asthmatic subjects (n=15):

          -  Forced expiratory volume in one second (FEV1) of no less than 70% of predicted
             (exhaled NO greater than or equal to 15 ppb; flow 50 ml/s)

          -  Clinically stable (steroid-na√Øve or taking no &gt; 600 mcg/day of inhaled steroids)

          -  Able to comprehend and grant a written informed consent

        Exclusion Criteria:

          -  Currently smoking

          -  Any lung disease other than asthma which may interfere with the study

          -  Treatment within the last 4 weeks with oral steroids

          -  Respiratory infection within 4 weeks prior to entry into the trial

          -  Females who are pregnant or lactating

          -  History of current or past drug or alcohol abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sergei A Kharitonov, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <zip>SW3 6LY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>June 3, 2015</last_update_submitted>
  <last_update_submitted_qc>June 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2015</last_update_posted>
  <keyword>Healthy Volunteers</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pimagedine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

